Arbutus BioPharma rockets toward functional cure milestone amid $2.25B Moderna settlement
Arbutus Biopharma (NASDAQ:ABUS) today reported a landmark set of financial and clinical results for the fourth quarter and full year ended December 31, 2025.
Arbutus Biopharma (NASDAQ:ABUS) today reported a landmark set of financial and clinical results for the fourth quarter and full year ended December 31, 2025.
BioLineRx (NASDAQ:BLRX) today announced its audited financial results for the full year ended December 31, 2025, detailing a period of significant fiscal discipline and pipeline maturation.
Bausch + Lomb (NYSE:BLCO) today unveiled positive topline results from its pivotal 24-month U.S. clinical trial of the ELIOS System, an innovative, implant-free procedure designed to treat elevated intraocular pressure (IOP) in patients with open-angle glaucoma.
Viatris (NASDAQ:VTRS) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR (venlafaxine hydrochloride) sustained-release capsules for the treatment of adults with generalized anxiety disorder (GAD).
Jacobs (NYSE:J) announced today the completion of its acquisition of the remaining equity interest in PA Consulting, a leading innovation and transformation consultancy.
Lithium Argentina (NYSE:LAR) today announced its financial and operational results for the fourth quarter and full year ended December 31, 2025, marking a year of significant operational maturity.
Finnair has reached a definitive agreement with Embraer (NYSE:EMBJ) to acquire up to 46 E195-E2 aircraft, marking one of the largest single investments in the Finnish flag carrier’s 102-year history.
Grab Holdings (NASDAQ:GRAB) today announced a definitive agreement to acquire the Taiwanese operations of foodpanda from Delivery Hero for $600 million in cash.
McEwen (NYSE:MUX) today announced a significant milestone in its strategy to double corporate production, releasing a new Mineral Resource Estimate (MRE) for its 100%-owned Tartan Mine Project near Flin Flon, Manitoba.
Ennis (NYSE:EBF), a premier manufacturer of business forms and essential printed products, announced today that its Board of Directors has declared a quarterly cash dividend of $0.25 per share on the company’s common stock.
Gamehaus (NASDAQ:GMHS) today announced its unaudited financial results for the second quarter of fiscal 2026, ended December 31, 2025, revealing a quarter defined by significantly improved bottom-line efficiency.
Nexra, the dedicated Operations & Maintenance (O&M) division of Cadeler (NYSE:CDLR), confirmed today the signing of an additional firm contract for a maintenance campaign in Taiwan scheduled for completion in 2026.